In the Thalassemia International Federation guidelines, it is suggested that transfusion should be performed every two–four weeks to keep the pretransfusion Hb above 9–10.5 g/L or > 11–12 g/dL in thalassemia with cardiac complications [8]. This evidence concerns the gene GSTM1 and thalassemia.